Coal tar litigation
This article was originally published in The Rose Sheet
Executive Summary
State of California, Tegrin dandruff shampoo marketer Reedco reach tentative settlement in Prop 65 coal tar litigation. Trial against Reedco, a subsidiary of GlaxoSmithKline's Block Drug and the sole remaining defendant in the litigation, had been scheduled for May 13. Settlement is similar to those by other manufacturers, marketers of coal-tar containing shampoos and creams who agreed to place warnings on certain products, pay monetary penalties ranging from a few thousand to several hundred thousand dollars (1"The Rose Sheet" Feb. 18, 2002, In Brief)...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.